Openwater Internet, Inc. Patent Pledge

1. Introduction

Openwater is engaged in the research, design, development, manufacturing and production of novel imaging and ultrasonic technologies and diagnostic and therapeutic devices including software and AI intended to have broad applications in the treatment of various medical conditions, including COVID-19/Long COVID, vaccine injury, neurodegenerative ailements, cancer, and other fields of medicine, brain computer interface and wellness and enhancement. This pledge, which embodies Openwater’s founding ethos, is intended to continue and encourage the advancement of medical science and biotechnology and ensure equitable global medical access, thereby benefiting Openwater, other medical and biotechnology companies, and individuals across the world, regardless of income. The below guidelines demonstrate our commitment to the foregoing advancements and detail how Openwater is implementing its open source development model.

​2. Definitions

  • “Openwater Open Source Products” means any product (including hardware) based on a design that Openwater has released under the terms of the Creative Commons Attribution – ShareAlike 4.0 International license at https://creativecommons.org/licenses/by-sa/4.0/deed.en or on improvements, enhancements or derivatives of or relating to such design, as well any designs that are disclosed in the Pledged Patents as defined below, or on improvements, enhancements or derivatives of or relating to such design.

  • “Openwater Derived Open Source Software” means any software based on source code or object code that Openwater has released under the terms of the GNU Affero General Public License, Version 3, released November 19, 2007 available at https://www.gnu.org/licenses/agpl-3.0.en.html or any similar open source license that satisfies any version of “The Open Source Definition” provided by the Open Source Initiative at opensource.org/osd or any version of “The Free Software Definition” provided by the Free Software Foundation at gnu.org/philosophy/free-sw.html.

  • “Openwater”, “our", or “we” means Open Water Internet, Inc.

  • “Pledge” means the pledge in Section 3 below.

  • “Pledged Patents” means (i) all of the patents and patent applications listed at https://www.openwater.health/patents, (ii) all future patents exclusively owned by Openwater, regardless of whether we have posted such patents online, and (iii) patents jointly developed by Openwater and a third party (such patents, “Jointly Developed Patents”).

  • “You” means any individual or entity that uses or accesses or exercises any rights in the Pledged Patents.

3. Pledge

Other than as described in the “Defensive Termination” section below, we pledge to each person or entity that manufactures, develops, sells, offer for sale, distributes, imports, exports or uses any (a) Openwater Open Source Products or (b) Openwater Derived Open Source Software (in each case, in compliance with any applicable licenses under which they are distributed by Openwater), that Openwater will not bring a lawsuit or other legal proceeding against you for patent infringement under any Pledged Patents based on your development, manufacture, use, sale, offer for sale, lease, license, exportation, importation or distribution of such Openwater Open Source Products or Openwater Derived Open Source Software in such manner, provided that, with respect to Jointly Developed Patents, Openwater is only making this pledge with respect to our right to bring a legal proceeding for patent infringement and does not represent that a third party will honor this Pledge. The preceding pledge does not apply to any infringement of the Pledged Patents by Openwater Derived Open Source Software combined with special purpose hardware or with software that is not Openwater Derived Open Source Software.

4. Legal Effect

It is Openwater’s intent that this Pledge is legally binding and enforceable against Openwater and its controlled affiliates, and their successors and assigns (“Openwater Parties”). Accordingly, if an Openwater Party sells, exclusively licenses, assigns, or otherwise transfers a Pledged Patent to any person or entity, that Openwater Party will be obligated to require that person or entity to agree, in writing, to abide by the Pledge and to require the same of any subsequent transferees.

5. No Warranties or Assurances

Other than what we’ve explicitly described in the Pledge, there are no other rights, licenses, or obligations are undertaken, granted, received, or waived—whether by implication, estoppel, or otherwise by this Pledge. Additionally, Openwater cannot guarantee that The Pledge may be honored in all jurisdictions. The Pledge is not an assurance that any of the Pledged Patents do or may cover any particular software or hardware or are enforceable or that any activities covered by the Pledge will not infringe patents or other intellectual property rights of a third party. This Pledge does not cover patents owned exclusively by third parties, and with respect to any Jointly Developed Patents, it only extends to our ability to waive our rights in such Jointly Developed Patents, and not any other third party. Unless explicitly set forth in a separate agreement between you and Openwater, Openwater will not be liable to a party relying on the Pledge for related claims brought by another based on infringement of intellectual property rights or otherwise.

6. Defensive Termination

Openwater makes this Pledge to foster innovation in medical imaging, diagnostics and advanced therapeutics, and other related technologies and areas that may be able to benefit from Openwater Open Source Products. To that end and to avoid the possibility that someone may abuse the Pledge, the Openwater Parties reserve the right (“Defensive Termination”) to terminate the Pledge at any time with respect to any person or entity if that person or entity (or an affiliate or agent thereof) engages in any of the following activity:

  1. Files (or threatens to file, whether orally or in writing) a lawsuit or other proceeding alleging patent infringement based, in whole or in part, on any products or services developed, used, imported, manufactured, offered for sale, sold, or distributed by or on behalf of an Openwater Party;​

  2. Challenges (or threatens to challenge, whether orally or in writing) in a lawsuit, opposition, inter partes review, or other proceeding the validity or enforceability of a Pledged Patent; 

  3. Has a financial interest in, or provides voluntary assistance to the filing or prosecution of, any proceeding or challenge as described in (1) or (2); 

  4. Previously owned or controlled a patent that is asserted as described in paragraph (1); or 

  5. Engages in illegal activity as determined by a competent jurisdiction pursuant to the rules of due process and the like in said jurisdiction

No delay or omission by an Openwater Party in exercising its right of Defensive Termination will impair or be construed as a waiver of such right by any Openwater Party.

If an Openwater Party terminates the Pledge pursuant to this section, that termination will void the Pledge ab initio. That is to say, it will have the same effect as if the Pledge had never been extended to that person or entity in the first instance. Openwater, in its sole discretion, shall determine if and when, and the manner and terms on which, the Pledge shall again extend to that person or entity after an Openwater Party has exercised Defensive Termination.

 

Patents

Ref: OPENWP101

 

Country: United States
Status: Issued
Patent Number 9,730,649
Issue Date August 15, 2017
Pub Number -
Filing Date September 13, 2016

 

Short Summary

The technology in this application enables 3D optical imaging of a diffuse medium (such as tissue). In a medical context, this could be used to identify tumors. Optical imaging is much less expensive than MRI imaging and is possible with off-the-shelf consumer electronics such as LCDs, CMOS image sensors, and lasers. In operation, a laser illuminates an LCD with infrared light. Driving different holographic 2D images onto the LCD allows for "steering" the laser light to different regions (voxels) in the tissue. A CMOS image sensor captures an interference image of an exit signal of the laser light exiting the tissue interfering with a reference wavefront (same wavelength as the laser light). Analysis of the interference image reveals the characteristics of the voxel.

 

Type: Utility: Non- Provisional
Application No: 15/264,088

 

Optical Imaging of Diffuse Medium

 

Ref: OPENWP101C1

 

Country: United States
Status: Issued
Patent Number 10,772,574
Issue Date September 15, 2020
Pub Number -
Filing Date July 26, 2017
 
 
Short Summary

The technology in this application enables 3D optical imaging of a diffuse medium (such as tissue). In a medical context, this could be used to identify tumors. Optical imaging is much less expensive than MRI imaging, for example, and is possible with off-the-shelf consumer electronics such as LCDs, CMOS image sensors, and lasers. In operation, a laser illuminates an LCD with infrared light. Driving different holographic 2D images onto the LCD allows for "steering" the laser light to different regions (voxels) in the tissue. A CMOS image sensor captures an interference image of an exit signal of the laser light exiting the tissue interfering with a reference wavefront (same wavelength as the laser light). Analysis of the interference image reveals the characteristics of the voxel.

 

Type: Utility: Non- Provisional
Application No: 15/660,151

 

Imaging with Infrared Imaging Signals

 

Ref: OPENWP101C2

 

Country: United States
Status: Issued
Patent Number 11,547,370
Issue Date January 10, 2023
Pub Number 20200383646
Filing Date August 14, 2020
 
Short Summary

The technology in this application enables 3D optical imaging of a diffuse medium (such as tissue). In a medical context, this could be used to identify tumors. Optical imaging is much less expensive than MRI imaging, for example, and is possible with off-the-shelf consumer electronics such as LCDs, CMOS image sensors, and lasers. In operation, a laser illuminates an LCD with infrared light. Driving different holographic 2D images onto the LCD allows for "steering" the laser light to different regions (voxels) in the tissue. A CMOS image sensor captures an interference image of an exit signal of the laser light exiting the tissue interfering with a reference wavefront (same wavelength as the laser light). Analysis of the interference image reveals the characteristics of the voxel.

 

Type: Utility: Non- Provisional
Application No: 17/002112

 

Method for Infrared Imaging

 

Ref: OPENWP101CN

 

Country: China
Status: Issued
Patent Number ZL 2017800
Issue Date December 3, 2021
Pub Number -
Filing Date March 11, 2019
 
Short Summary

The technology in this application enables 3D optical imaging of a diffuse medium (such as tissue). In a medical context, this could be used to identify tumors. Optical imaging is much less expensive than MRI imaging and is possible with off-the-shelf consumer electronics such as LCDs, CMOS image sensors, and lasers. In operation, a laser illuminates an LCD with infrared light. Driving different holographic 2D images onto the LCD allows for "steering" the laser light to different regions (voxels) in the tissue. A CMOS image sensor captures an interference image of an exit signal of the laser light exiting the tissue interfering with a reference wavefront (same wavelength as the laser light). Analysis of the interference image reveals the characteristics of the voxel.

 

Type: Utility: Foreign
Application No: 2.02E+11

 

Optical Imaging of Diffuse Medium

 

Ref: OPENWP101CN

 

Country: China
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date November 22, 2021
 
Short Summary

The technology in this application enables 3D optical imaging of a diffuse medium (such as tissue). In a medical context, this could be used to identify tumors. Optical imaging is much less expensive than MRI imaging and is possible with off-the-shelf consumer electronics such as LCDs, CMOS image sensors, and lasers. In operation, a laser illuminates an LCD with infrared light. Driving different holographic 2D images onto the LCD allows for "steering" the laser light to different regions (voxels) in the tissue. A CMOS image sensor captures an interference image of an exit signal of the laser light exiting the tissue interfering with a reference wavefront (same wavelength as the laser light). Analysis of the interference image reveals the characteristics of the voxel.

 

Type: Utility: Foreign
Application No: -

 

Optical Imaging of Diffuse Medium

 

Ref: OPENWP101EP

 

Country: European Patent Office
Status: Issued
Patent Number EP 3,512,413
Issue Date March 1, 2021
Pub Number 3512413
Filing Date February 14, 2019
 
Short Summary

The technology in this application enables 3D optical imaging of a diffuse medium (such as tissue). In a medical context, this could be used to identify tumors. Optical imaging is much less expensive than MRI imaging and is possible with off-the-shelf consumer electronics such as LCDs, CMOS image sensors, and lasers. In operation, a laser illuminates an LCD with infrared light. Driving different holographic 2D images onto the LCD allows for "steering" the laser light to different regions (voxels) in the tissue. A CMOS image sensor captures an interference image of an exit signal of the laser light exiting the tissue interfering with a reference wavefront (same wavelength as the laser light). Analysis of the interference image reveals the characteristics of the voxel.

 

Type: Utility: Foreign
Application No: 17851239.8

 

Optical Imaging of Diffuse Medium

 

Ref: OPENWP101PC

 

Country: WIPO
Status: Published
Patent Number -
Issue Date -
Pub Number 2018052555
Filing Date August 1, 2017
 
Short Summary

The technology in this application enables 3D optical imaging of a diffuse medium (such as tissue). In a medical context, this could be used to identify tumors. Optical imaging is much less expensive than MRI imaging and is possible with off-the-shelf consumer electronics such as LCDs, CMOS image sensors, and lasers. In operation a laser illuminates an LCD with infrared light. Driving different holographic 2D images onto the LCD allows for "steering" the laser light to different regions (voxels) in the tissue. A CMOS image sensor captures an interference image of an exit signal of the laser light exiting the tissue interfering with a reference wavefront (same wavelength as the laser light). Analysis of the interference image reveals the characteristics of the voxel.

 

Type: Utility: PCT
Application No: PCT/US17/44907

 

Optical Imaging of Diffuse Medium

 

Ref: OPENWP101PC

 

Country: United States
Status: Issued
Patent Number 10,775,741
Issue Date September 15, 2020
Pub Number -
Filing Date May 19, 2017
 
Short Summary

The application is about co-located image pixels and display pixels to enable reconstruction of a received wavefront in order to retransmit the received wavefront along a reverse-optical path. In the context of medical imaging, this allows the device to "focus" infrared light back to a voxel of tissue in order to determine the absorption (and corresponding blood flow) through the voxel. A device may include an image pixel array with co-located display pixels. Each display pixel may receive infrared light through a corresponding co-located image pixel. An optical transformation engine modulates infrared display light emitted by the display pixels in response to the light received by the co-located image pixel. When the display pixels are liquid crystal, the phase of the received infrared light may be measured by modulating the orientation of the liquid crystals in the display nixel that is positioned in front of the on The application is about co-located image pixels and display pixels to enable reconstruction of a received wavefront in order to retransmit the received wavefront along a reverse-optical path. In the context of medical imaging, this allows the device to "focus" infrared light back to a voxel of tissue in order to determine the absorption (and corresponding blood flow) through the voxel. A device may include an image pixel array with co-located display pixels. Each display pixel may receive infrared light through a corresponding co-located image pixel. An optical transformation engine modulates infrared display light emitted by the display pixels in response to the light received by the co-located image pixel. When the display pixels are liquid crystal, the phase of the received infrared light may be measured by modulating the orientation of the liquid crystals in the display nixel that is positioned in front of the on

 

Type: Utility: Non- Provisional
Application No: 15/984319

 

Co-locating Imaging and Display Pixel

 

Ref: OPENWP102x

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date May 22, 2017
Short Summary

The technology in this application enables extracting phase data from an infrared imaging signal exiting tissue using optical transformation logic and then quickly generating a hologram from the phase data so that the hologram can be driven onto a display that reconstructs (and retransmits) the incoming infrared image signal back into the tissue in a reverse optical path.

 

Type: Utility: Provisional
Application No: 62/509704

 

Optical Imaging Pixels

 

Ref: OPENWP103

 

Country: United States
Status: Issued
Patent Number 10,778,911
Issue Date September 15, 2020
Pub Number 10778911
Filing Date March 31, 2018
 
Short Summary

The technology in this application enables 3D optical imaging of a diffuse medium (such as tissue). In a medical context, this could be used to identify tumors. Optical imaging is much less expensive than MRI imaging, for example, and is possible with off-the-shelf consumer electronics such as LCDs, CMOS image sensors, and lasers. In operation, a laser illuminates an LCD with infrared light. Driving different holographic 2D images onto the LCD allows for "steering" the laser light to different regions (voxels) in the tissue. A CMOS image sensor captures an interference image of an exit signal of the laser light exiting the tissue interfering with a reference wavefront (same wavelength as the laser light). Analysis of the interference image reveals the characteristics of the voxel.

 

Type: Utility: Non- Provisional
Application No: 15/942.480

 

Optical Transformation Device for Imaging

 

Ref: OPENWP103PC

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 14, 2018
 
Short Summary

This application is directed to a specific hardware implementation for implementing the methods of OPENWP103 that includes placing a beam splitter between an image sensor and a display placed 90 degrees offset from each other. See FIG. 1A-1C. The beam splitter functions to reflect an infrared reference wavefront to the image sensor so the image sensor can capture the interference pattern between the infrared reference wavefront and an incoming infrared image signal (received from tissue). The beam splitter also serves to reflect (and transmit) a reconstructed infrared wavefront back into the tissue.

 

Type: Utility: PCT
Application No: PCT/US2018/022241

 

Optical Transformation Device for Imaging

 

Ref: OPENWP104

 

Country: United States
Status: Issued
Patent Number 10,778,912
Issue Date September 15, 2020
Pub Number 10778912
Filing Date March 31, 2018
 
Short Summary

This application is directed to a specific hardware implementation for implementing the methods of OPENWP 103 that includes placing an image sensor behind an LCD display. See FIG. 2A-2C.

 

Type: Utility: Non- Provisional
Application No: 15/942,482

 

System and Device for Optical Transformation

Ref: OPENWP104C1

 

Country: United States
Status: Issued
Patent Number 11,252,343
Issue Date February 15, 2022
Pub Number 20200396396
Filing Date August 28, 2020
 
Short Summary

This application is directed to a specific hardware implementation for implementing the methods of OPENWP103 that includes placing a beam splitter between an image sensor and a display placed 90 degrees offset from each other. See FIG. 1A-1C. The beam splitter functions to reflect an infrared reference wavefront to the image sensor so the image sensor can capture the interference pattem between the infrared reference wavefront and an incoming infrared image signal (received from tissue). The beam splitter also serves to reflect (and transmit) a reconstructed infrared wavefront back into the tissue.

 

Type: Utility: Non- Provisional Continuation
Application No: 17/005008

 

Optical Imaging Through Display

 

Ref: OPENWP104CN

 

Country: China
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date September 30, 2020
 
Short Summary

This application is directed to a specific hardware implementation for implementing the methods of OPENWP103 that includes placing a beam splitter between an image sensor and a display placed 90 degrees offset from each other. See FIG. 1A-1C. The beam splitter functions to reflect an infrared reference wavefront to the image sensor so the image sensor can capture the interference pattem between the infrared reference wavefront and an incoming infrared image signal (received from tissue). The beam splitter also serves to reflect (and transmit) a reconstructed infrared wavefront back into the tissue.

 

Type: Utility: Foreign
Application No: 2.02E+11

 

System and Device for Optical Transformation

 

Ref: OPENWP104EP

 

Country: European Patent Office
Status: Published
Patent Number -
Issue Date -
Pub Number 3373167 A0
Filing Date October 27, 2020
 
Short Summary

This application is directed to a specific hardware implementation for implementing the methods of OPENWP103 that includes placing a beam splitter between an image sensor and a display placed 90 degrees offset from each other. See FIG. 1A-1C. The beam splitter functions to reflect an infrared reference wavefront to the image sensor so the image sensor can capture the interference pattem between the infrared reference wavefront and an incoming infrared image signal (received from tissue). The beam splitter also serves to reflect (and transmit) a reconstructed infrared wavefront back into the tissue.

 

Type: Utility: Foreign
Application No: 19776668.6

 

System and Device for Optical Transformation

Ref: OPENWP104PC

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 14, 2019
 
Short Summary

The technology in this application enables capturing 3D images of diffuse mediums (e.g. tissue) using extraction logic to isolate the intensity data from image pixels. A hologram generated by outputs of the extraction logic can be used to reconstruct (and retransmit) the incoming infrared image signal. An interference pattem between an infrared reference beam and an incoming infrared image signal (received from tissue) is captured by an image pixel array. The extraction logic (1) performs a Fast Fourier transform on the interference pattern; (2) isolates frequencies representing the interference pattern; (3) generates a spatial domain image on the isolated frequencies; and (4) extracts phase data from the spatial domain image. A hologram can be generated from the phase data and a display may be driven with the hologram to reconstruct the incoming infrared image signal.

 

Type: Utility: PCT
Application No: PCT/US2018/022258

 

System and Device for Optical Transformation

Ref: OPENWP105

 

Country: United States
Status: Issued
Patent Number 10,506,181
Issue Date December 10, 2019
Pub Number 20190306437
Filing Date March 31, 2018
 
Short Summary

The technology in this application enables capturing 3D images of diffuse mediums (e.g. tissue) using extraction logic to isolate the intensity data from image pixels. A hologram generated by outputs of the extraction logic can be used to reconstruct (and retransmit) the incoming infrared image signal. An interference pattem between an infrared reference beam and an incoming infrared image signal (received from tissue) is captured by an image pixel array. The extraction logic (1) performs a Fast Fourier transform on the interference pattern; (2) isolates frequencies representing the interference pattern; (3) generates a spatial domain image on the isolated frequencies; and (4) extracts phase data from the spatial domain image. A hologram can be generated from the phase data and a display may be driven with the hologram to reconstruct the incoming infrared image signal.

 

Type: Utility: Non- Provisional
Application No: 15/942,479

 

Device for Optical Imaging

Ref: OPENWP105C1

 

Country: United States
Status: Issued
Patent Number 10,880,497
Issue Date December 29, 2020
Pub Number -
Filing Date October 25, 2019
 
Short Summary

The technology in this application enables capturing 3D images of diffuse mediums (e.g. tissue) using extraction logic to isolate the intensity data from image pixels. A hologram generated by outputs of the extraction logic can be used to reconstruct (and retransmit) the incoming infrared image signal. An interference pattem between an infrared reference beam and an incoming infrared image signal (received from tissue) is captured by an image pixel array. The extraction logic (1) performs a Fast Fourier transform on the interference pattern; (2) isolates frequencies representing the interference pattern; (3) generates a spatial domain image on the isolated frequencies; and (4) extracts phase data from the spatial domain image. A hologram can be generated from the phase data and a display may be driven with the hologram to reconstruct the incomina infrared image sianal.

 

Type: Utility: Non- Provisional
Application No: 16/664,187

 

Optical Imaging with Ultrasonic Signal

Ref: OPENWP105PC

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number 20200059611
Filing Date March 14, 2019
 
Short Summary

This application is for a compact optical element for generating a reference wavefront for optical imaging. For example, a fiber optic can carry a laser signal into the compact optical element and a diffractive optical element within the optical element can expand, collimate, and deliver a reference wavefront at a desired angle with respect to an image sensor.

 

Type: Utility: PCT
Application No: PCT/US2018/022264

 

Device for Optical Imaging

Ref: OPENWP107

 

Country: United States
Status: Issued
Patent Number 10,966,612
Issue Date April 6, 2021
Pub Number 20190380587
Filing Date June 12, 2019
 
Short Summary

This application is for a compact optical element for generating a reference wavefront for optical imaging. For example, a fiber optic can carry a laser signal into the compact optical element and a diffractive optical element within the optical element can expand, collimate, and deliver a reference wavefront at a desired angle with respect to an image sensor.

 

Type: Utility: Non- Provisional
Application No: 16/439,631

 

Expanding Beam Optical Element

Ref: OPENWP107x

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date June 14, 2018
 
Short Summary

This application refers to a device or system illuminates a diffuse medium with an infrared light while an ultrasound emitter is focused on a particular voxel. The infrared light encountering the particular voxel may be wavelength-shifted by the ultrasonic signal. The wavelength-shifted infrared imaging signal can be measured by a light detector (e.g. image pixel array). Extraction logic may isolate the wavelength-shifted infrared imaging signal and extract intensity data and then populate a voxel value of a composite image with the intensity data. The composite image may include a three-dimensional image of the diffuse medium.

 

Type: Utility: Provisional
Application No: 62/684900

 

Reference Beam Source for Imaging Device

Ref: OPENWP108x

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date September 14, 2018
 
Short Summary

This application is directed to an optical element having a curved, partially reflective layer to combine an imaging signal with a reference wavefront. See element 483 in FIG. 4. The curved partially reflective layer redirects the reference wavefront to the image sensor at an engineered angle while also passing the infrared exit signal to interfere with the reference wavefront.

 

Type: Utility: Provisional
Application No: 62/731308

 

Devices and Techniques for Imaging Diffuse Me

Ref: OPENWP109

 

Country: United States
Status: Issued
Patent Number 10,962,929
Issue Date March 30, 2021
Pub Number 20200089165
Filing Date November 1, 2018
 
Short Summary

This application enables dual-wavelength optical imaging of tissue in a single image and the difference between the different wavelengths is representative of an absorption level of the voxel that was being imaged. The absorption of the voxel is tied to oxygenation and deoxygenation of blood and bloodflow. When multiple voxels are imaged, a 3D image showing absorption-level differences can be generated.

 

Type: Utility: Non- Provisional
Application No: 16/204,940

 

Interference Optics for Optical Imaging Device

Ref: OPENWP110

 

Country: United States
Status: Issued
Patent Number 10,955,406
Issue Date March 23, 2021
Pub Number 20200249154
Filing Date February 5, 2019
 
Short Summary

Pulsed lasers emit light pulses that have variations in intensity and duration. When pulsed lasers are used for optical imaging, the varying light pulses affect the intensity of the received signal voxel-to-voxel. In this invention, an energy meter (e.g. photodiode) measures the energy level of the light pulses emitted from a laser in an optical imaging system. Normalization logic receives the energy level from energy meter and normalizes the exit signal in response to the energy level.

 

Type: Utility: Non- Provisional
Application No: 16/267,957

 

Diffuse Optical Imaging with Multiple Beams

Ref: OPENWP111

 

Country: United States
Status: Issued
Patent Number 10,874,370
Issue Date December 29, 2020
Pub Number -
Filing Date January 28, 2019
 
Short Summary

This invention is an multi-tip apparatus to enable optical imaging of tissue. Image sensors and/or laser outputs (from fiber optics) are included in tips mounted to flexible members of the apparatus, which allows the tips to conform around the shape of the tissue being imaged. A body handle of the apparatus may include an ultrasonic emitter and the laser to illuminate the tissue by way of fiber optics that run through the flexible members to the tips.

 

Type: Utility: Non- Provisional
Application No: 16/260,015

 

Pulse Measurement in Optical Imaging

Ref: OPENWP112

 

Country: United States
Status: Issued
Patent Number 11,320,783
Issue Date May 3, 2022
Pub Number 20200085309
Filing Date February 19, 2019
 
Short Summary

This invention is a laser oscillator and amplifier that can be used for optical imaging. A seed laser is optically coupled to am optical amplifier configured to direct the amplified laser light into a diffuse medium.

 

Type: Utility: Non- Provisional
Application No: 16/279,951

 

Flexible Tip Optical Imaging

Ref: OPENWP113x

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date July 31, 2019
 
Short Summary

This invention is a multi-channel laser that can be used for optical imaging. A seed laser is optically coupled to a plurality of optical amplifiers. An optical distribution assembly distributes the seed laser light to each optical amplifier and the optical amplifiers are configured to direct the amplified laser light into a diffuse medium (without the amplified laser light being optically combined back into the same laser beam).

 

Type: Utility: Provisional
Application No: 62/880944

 

Laser Oscillator and Amplifier for Optical Imagin

Ref: OPENWP114

 

Country: United States
Status: Issued
Patent Number 11,581,696
Issue Date February 14, 2023
Pub Number 20210050704
Filing Date August 14, 2019
 
Short Summary

This invention is a multi-channel laser that can be used for optical imaging. A seed laser is optically coupled to a plurality of optical amplifiers. An optical distribution assembly distributes the seed laser light to each optical amplifier and the optical amplifiers are configured to direct the amplified laser light into a diffuse medium (without the amplified laser light being optically combined back into the same laser beam).

 

Type: Utility: Provisional
Application No: 16/540,514

 

Multi-Channel Laser

Ref: OPENWP114C1

 

 

Country: United States
Status: Published
Patent Number -
Issue Date -
Pub Number 20230130928
Filing Date December 23, 2022
Short Summary

This invention is a multi-channel laser that can be used for optical imaging. A seed laser is optically coupled to a plurality of optical amplifiers. An optical distribution assembly distributes the seed laser light to each optical amplifier and the optical amplifiers are configured to direct the amplified laser light into a diffuse medium (without the amplified laser light being optically combined back into the same laser beam).

 

Type: Utility: Continuation
Application No: 18/086.182

 

Multi-Channel Laser

Ref: OPENWP114CN

 

Country: China
Status: Published
Patent Number -
Issue Date -
Pub Number CN 114207961
Filing Date February 9, 2022
 
Short Summary

This invention is a multi-channel laser that can be used for optical imaging. A seed laser is optically coupled to a plurality of optical amplifiers. An optical distribution assembly distributes the seed laser light to each optical amplifier and the optical amplifiers are configured to direct the amplified laser light into a diffuse medium (without the amplified laser light being optically combined back into the same laser beam).

 

Type: Utility: Foreign
Application No: CN 114207961 A

 

Multi-Channel Laser

Ref: OPENWP114EP

 

Country: European Patent Office
Status: Published
Patent Number -
Issue Date -
Pub Number 4014289 AD
Filing Date March 11, 2022
Short Summary

This invention is a multi-channel laser that can be used for optical imaging. A seed laser is optically coupled to a plurality of optical amplifiers. An optical distribution assembly distributes the seed laser light to each optical amplifier and the optical amplifiers are configured to direct the amplified laser light into a diffuse medium (without the amplified laser light being optically combined back into the same laser beam).

 

Type: Utility: Foreign
Application No: 20852065

 

Multi-Channel Laser

Ref: OPENWP114PC

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date August 13, 2020
Short Summary

This invention enables an ultrasound signal and optical signals to propagate along the same optical path for imaging purposes. When ultrasound and optical imaging are combined, this allows for imaging of the same voxel with dual modalities. A glass element is fixed in an index-matching liquid having the same refractive index as the glass element. The glass element is immersed in an enclosure and the glass element redirects the ultrasonic signal while the optical signal (e.g. infrared) propagates through the glass element (along the same optical path as the ultrasound signal). The optical signal is not refracted by the glass element because the index matching fluid surrounding the glass element is the same refractive index as the glass element.

 

Type: Utility: PCT
Application No: PCT/US20/46226

 

Multi-Channel Laser

Ref: OPENWP114PC

 

Country: United States
Status: Issued
Patent Number 11,320,370
Issue Date May 3, 2022
Pub Number 20200408681
Filing Date June 25, 2020
 
Short Summary

This invention enables an ultrasound signal and optical signals to propagate along the same optical path for imaging purposes. When ultrasound and optical imaging are combined, this allows for imaging of the same voxel with dual modalities. A glass element is fixed in an index matching liquid having the same refractive index as the Sglass element. The glass element is immersed in a disclosure and the glass element redirects the ultrasonic signal while the optical signal (e.g. infrared) propagates through the glass element (along the same optical path as the ultrasound signal). The optical signal is not refracted by the glass element because the index matching fluid surrounding the glass element is the same refractive index as the glass element.

 

Type: Utility: Non-Provisional
Application No: 16/912,450

 

Apparatus For Combining Optical And Acoustic Stabilization

Ref: OPENWP115C1

 

Country: aid Issue Fee
Status: Issued
Patent Number -
Issue Date -
Pub Number 20220228980
Filing Date March 31, 2022
 
Short Summary

This invention is directed to a laser amplifier that reduces or eliminates optical chirp in pulsed laser - especially for high powered pulsed lasers. The optical amplifier includes a waveguide and a diffraction grating positioned between two

 

Type: Utility: Continuation
Application No: 17/710,869

 

Apparatus For Combining Optical And Acoustic Stabilization

Ref: OPENWP117

 

Country: United States
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date September 17, 2020
 
Short Summary

semiconductor layers. The semiconductor optical amplifier emits output light through a 2D surface of one of the semiconductor layers. The diffraction grating is a 1D or 2D photonic crystalline structure that directs light to the waveguide to facilitate amplification through constructive interference and directs/deflects light into or out of the waveguide by constructive interference.

 

Type: Utility: PCT
Application No: 17/024461

 

A Semiconductor Optical Amplifer

Ref: OPENWP117x

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date September 17, 2018
 
Short Summary

This invention is directed to a laser amplifier that reduces or eliminates optical chirp in pulsed laser - especially for high powered pulsed lasers. The optical amplifier includes a waveguide and a diffraction grating positioned between two semiconductor layers. The semiconductor optical amplifier emits output light through a 2D surface of one of the semiconductor layers. The diffraction grating is a 1D or 2D photonic crystalline structure that directs light to the waveguide to facilitate amplification through constructive interference and directs/deflects light into or out of the waveguide by constructive interference.

 

Type: Utility: Non- Provisional
Application No: 62/901687

 

High Peak Power Single Mode Semiconductor

Ref: OPENWP118

 

Country: United States
Status: Abandone
Patent Number -
Issue Date -
Pub Number 20210153742
Filing Date November 21, 201
 
Short Summary

This invention allows for imaging measurements from an unshifted reference beam having the same wavelength as the laser source that illuminates the tissue. In prior optical imaging contexts, the reference beam that interfered with an infrared exit signal would be shifted to match the wavelength generated from an ultrasonic signal encountering the infrared illumination light. In this invention, the absence of the wavelength-shifted light is recorded by subtracting from a base infrared signal that is captured when no ultrasonic signal propagates through the tissue.

 

Type: Utility: Non- Provisional
Application No: 16/692898

 

System for optical imaging with unshifted referer

Ref: OPENWP119

 

Country: United States
Status: Issued
Patent Number 11,622,686
Issue Date April 11, 2023
Pub Number 20210153743
Filing Date November 21, 201
 
Short Summary

This invention allows for imaging measurements from an unshifted reference beam having the same wavelength as the laser source that illuminates the tissue. In prior optical imaging contexts, the reference beam that interfered with an infrared exit signal would be shifted to match the wavelength generated from an ultrasonic signal encountering the infrared illumination light. In this invention, the absence of the wavelength-shifted light is recorded by subtracting from a base infrared signal that is captured when no ultrasonic signal propagates through the tissue.

 

Type: Utility: PCT
Application No: 16/692945

 

Optical Imaging with unshifted reference beam

Ref: OPENWP120

 

Country: United States
Status: Issued
Patent Number 11,559,208
Issue Date January 24, 2023
Pub Number -
Filing Date May 19, 2020
 
Short Summary

This invention increases the accuracy of optical imaging that is assisted by ultrasound by providing a "light scattering layer that can facilitate transmission of the ultrasound signal. A gel wax layer may be used as the light scattering layer. By measuring the wavelength-shift imparted by an ultrasound signal on a reference beam in a controlled/known medium (e.g. gel wax layer), the measurement of an infrared signal in an unknown medium (e.g. tissue) can be calibrated.

 

Type: Utility: Non- Provisional
Application No: 16/878502

 

Imaging with Scattering Layer

Ref: OPENWP120

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 30, 2021
 
Short Summary

This invention increases the accuracy of optical imaging that is assisted by ultrasound by providing a "light scattering layer" that can facilitate transmission of the ultrasound signal. A gel wax layer may be used as the light scattering layer. By measuring the wavelength-shift imparted by an ultrasound signal on a reference beam in a controlled/known medium (e.g. gel wax layer), the measurement of an infrared signal in an unknown medium (e.g. tissue) can be calibrated.

 

Type: Utility: Provisional
Application No: PCT/US21/24986

 

Imaging with Scattering Layer

Ref: OPENWP121

 

Country: United States
Status: Issued
Patent Number 11,259,706
Issue Date March 1, 2022
Pub Number 20210364429
Filing Date May 19, 2020
 
Short Summary

This invention increases the accuracy of optical imaging that is assisted by ultrasound by using two optical wavelengths where one wavelength propagates within a light scattering layer. A first signal is measured of the ultrasound signal's impact on a first wavelength propagating within the light scattering layer (e.g. gel wax layer). This first signal represents a mechanical contrast of a voxel being imaged. A second signal is measured of the ultrasound signal's impact on a second wavelength propagating within tissue. The second signal represents both mechanical contrast and optical contrast. Thus, the optical contrast of a voxel can be determined by subtracting the first signal from the second signal.

 

Type: Utility: Non- Provisionsal
Application No: 16/878,513

 

Dual Wavelength Imaging and Out of Sample Optical

Ref: OPENWP121PC

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 30, 2021
 
Short Summary

This invention increases the accuracy of optical imaging that is assisted by ultrasound by using two optical wavelengths where one wavelength propagates within a light scattering layer. A first signal is measured of the ultrasound signal's impact on a first wavelength propagating within the light scattering layer (e.g. gel wax layer). This first signal represents a mechanical contrast of a voxel being imaged. A second signal is measured of the ultrasound signal's impact on a second wavelength propagating within tissue. The second signal represents both mechanical contrast and optical contrast. Thus, the optical contrast of a voxel can be determined by subtracting the first signal from the second signal.

 

Type: Utility: PCT
Application No: PCT/US21/24988

 

Dual Wavelength Imaging and Out of Sample Optical

Ref: OPENWP121PC

 

Country: United States
Status: Issued
Patent Number 11,819,318
Issue Date -
Pub Number 20210330202
Filing Date June 18, 2020
 
Short Summary

This invention enables blood flow measurements in tissue based on coherent light values. A laser pulse is directed into the tissue. An image is captured of the diffuse laser light exiting the tissue. A coherence value of the diffuse laser light is determined. The blood flow rate is determined from the coherence value.

 

Type: Utility: Non- Provisional
Application No: 16/904,572

 

Optical Imaging from Light Coherence

Ref: OPENWP122CN

 

Country: China
Status: Published
Patent Number -
Issue Date -
Pub Number CN 115516849
Filing Date October 26, 2022
 
Short Summary

This invention enables blood flow measurements in tissue based on coherent light values. A laser pulse is directed into the tissue. An image is captured of the diffuse laser light exiting the tissue. A coherence value of the diffuse laser light is determined. The blood flow rate is determined from the coherence value.

 

Type: Utility: Non- Provisional
Application No: CN 115516849

 

Optical Imaging from Light Coherence

Ref: OPENWP122PC

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 30, 2021
 
Short Summary

This invention enables blood flow measurements in tissue based on coherent light values. A laser pulse is directed into the tissue. An image is captured of the diffuse laser light exiting the tissue. A coherence value of the diffuse laser light is determined. The blood flow rate is determined from the coherence value.

 

Type: Utility: PCT
Application No: PCT/US21/24984

 

Optical Imaging from Light Coherence

Ref: OPENWP122EP

 

Country: European Patent Office
Status: Published
Patent Number -
Issue Date -
Pub Number 4144078 A0
Filing Date October 13, 2022
 
Short Summary

This invention enables blood flow measurements in tissue based on coherent light values. A laser pulse is directed into the tissue. An image is captured of the diffuse laser light exiting the tissue. A coherence value of the diffuse laser light is determined. The blood flow rate is determined from the coherence value.

 

Type: Utility: Non- Provisional
Application No: 21797651.3

 

Optical Imaging from Light Coherence

Ref: OPENWP122x

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date April 27, 2020
 
Short Summary

This invention enables blood flow measurements in tissue based on coherent light values. A laser pulse is directed into the tissue. An image is captured of the diffuse laser light exiting the tissue. A coherence value of the diffuse laser light is determined. The blood flow rate is determined from the coherence value.

 

Type: Utility: Provisional
Application No: 63/016011

 

Optical Imaging from Light Coherence

Ref: OPENWP123

 

Country: United States
Status: Abandoned
Patent Number -
Issue Date -
Pub Number 20190072897
Filing Date August 7, 2018
 
Short Summary

The presently disclosure methods and apparatus allow focusing and imaging of translucent materials with decreased size and complexity. The presently disclosed methods and apparatus provide improved focusing and imaging with decreased size and weight, so as to allow use in many fields. In some embodiments, the spatial light modulator comprises at least about a million independently controllable light modulating pixels, which can provide increased resolution and allow focusing, phase conjugation, and scanning over large volumes of the translucent material to be scanned,

 

Type: Utility: Non- Provisionsal
Application No: 16/056,805

 

Applications of Diffuse Medium Imaging

Ref: OPENWP124

 

Country: United States
Status: Published
Patent Number -
Issue Date -
Pub Number 20230029744
Filing Date July 28, 2021
 
Short Summary

This invention enables intracranial blood flow measurements based on waveforms generated from optical imaging. Coherent light is directed in the head. Sequential images of exit signals are captured at intervals. Coherence values of the sequential images are determined. The coherence values are combined into a waveform and intracranial blood flow is determined based on the waveform.

 

Type: Utility: Non- Provisional
Application No: 17/387,279

 

Intracranial Diagnostics Using Optical Imaging of

Ref: OPENWP124PC

 

Country: United States
Status: Published
Patent Number -
Issue Date -
Pub Number -
Filing Date July 22, 2022
 
Short Summary

This invention enables intracranial blood flow measurements based on waveforms generated from optical imaging. Coherent light is directed in the head. Sequential images of exit signals are captured at intervals. Coherence values of the sequential images are determined. The coherence values are combined into a waveform and intracranial blood flow is determined based on the waveform.

 

Type: Ultility: PCT
Application No: PCT/US22/74079

 

Intracranial Diagnostics Using Optical Imaging of

Ref: OPENWP124PC

 

Country: United States
Status: Published
Patent Number -
Issue Date -
Pub Number 20230025985
Filing Date July 25, 2022
 
Short Summary

This invention provides a Large Vessel Occlusion (LVO) event notification to a medical center that is best positioned (in drive-time and in medical treatment capability) to provide stroke care to a patient. This reduces the time to medical care and allows the medical center to prepare for the patient's arrival. In stroke care. every second matters for patient outcomes.

 

Type: Utility: Non- Provisional
Application No: 17/872652

 

Large Vessel Occlusion Early Notification and Er

Ref: OPENWP125-02

 

Country: United States
Status: Published
Patent Number -
Issue Date -
Pub Number 20230026732
Filing Date July 25, 2022
 
Short Summary

This invention generates a Large Vessel Occlusion alert based on optical imaging. More specifically, a shallow optical measurement (e.g. 7 mm between light source and detector) and a deeper optical measurement (e.g. 30 mm between light source and detector) are made in the head. A ratio of the differences between shallow and deep measurements generated the LVO alert that may be provided to a screen to diagnose the patient. A head mounted medical device may perform the optical readings. In an implementation, the blood flow to the superficial temporal artery (STA) is temporary occluded to assist in the measurements.

 

Type: Utility: Non- Provisional
Application No: 17/872717

 

Large Vessel Occlusion Alert from Optical Measu

Ref: OPENWP125-01

 

Country: United States
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date July 25, 2022
 
Short Summary

This invention generates a Large Vessel Occlusion alert based on optical imaging. More specifically, a shallow optical measurement (e.g. 7 mm between light source and detector) and a deeper optical measurement (e.g. 30 mm between light source and detector) are made in the head. A ratio of the differences between shallow and deep measurements generated the LVO alert that may be provided to a screen to diagnose the patient. A head mounted medical device may perform the optical readings. In an implementation, the blood flow to the superficial temporal artery (STA) is temporary occluded to assist in the measurements.

 

Type: Utility: PCT
Application No: PCT/us22/74133

 

Large Vessel Occlusion Early Notification and Er

 

Ref: OPENWP125-02

 

Country: United States
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date July 25, 2022
 
Short Summary

This invention generates a Large Vessel Occlusion alert based on optical imaging. More specifically, a shallow optical measurement (e.g. 7 mm between light source and detector) and a deeper optical measurement (e.g. 30 mm between light source and detector) are made in the head. A ratio of the differences between shallow and deep measurements generated the LVO alert that may be provided to a screen to diagnose the patient. A head mounted medical device may perform the optical readings. In an implementation, the blood flow to the superficial temporal artery (STA) is temporary occluded to assist in the measurements.

 

Type: Utility: PCT
Application No: PCT/US22/74137

 

Large Vessel Occlusion Alert from Optical Measu

Ref: OPENWP125x

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date July 26, 2021
 
Short Summary

This invention generates a Large Vessel Occlusion alert based on optical imaging More specifically, a shallow optical measurement (e.g. 7 mm between light source and detector) and a deeper optical measurement (e.g. 30 mm between light source and detector) are made in the head. A ratio of the differences between shallow and deep measurements generated the LVO alert that may be provided to a screen to diagnose the patient. A head mounted medical device may perform the optical readings. In an implementation, the blood flow to the superficial temporal artery (STA) is temporary occluded to assist in the measurements.

 

Type: Utility: Provisional
Application No: 63/225671

 

Large Vessel Occlusion Point-of-Care Detection.

 

Ref: OPENWP127X

 

Country: United States
Status: Published
Patent Number -
Issue Date -
Pub Number WO 2023/09196
Filing Date November 16, 2021
 
Short Summary

This invention provides transcranial therapy with ultrasound. This may be an alternative to Transcranial Magnetic Stimulation (TMS). Depending on an input, different ultrasound profiles (e.g. power, duration, duty cycle, frequency) are utilized and different regions of the brain are targeted. These different therapies may stimulate certain behaviors (e.g. executive function) or inhibit other behaviors (e.g. addiction).

 

Type: Utility: Provisional
Application No: 63/279789

 

Wearable transcranial therapeutic Ultrasound

Ref: OPENWP127x2

 

Country: United States
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date September 7, 2022
 
Short Summary

This invention provides transcranial therapy with ultrasound. This may be an alternative to Transcranial Magnetic Stimulation (TMS). Depending on an input, different ultrasound profiles (e.g. power, duration, duty cycle, frequency) are utilized and different regions of the brain are targeted. These different therapies may stimulate certain behaviors (e.g. executive function) or inhibit other behaviors (e.g. addiction).

 

Type: Utility: Provisional
Application No: 63/404407

 

Therapeutic Inhibition and Stimulation with Trans

Ref: OPENWP128-01

 

Country: United States
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 16, 2023
Short Summary

This invention uses ultrasonic signals to harmonically excite (shatter) abnormal tissue while propagating through healthy tissue without damaging the healthy tissue. In this way, the ultrasound signals can target the destruction of tumors (abnormal tissue). Selecting the correct resonant ultrasound frequency to destroy the tumor may include additional medical imaging (MRI) to assisting in identify the abnormal tissue and mapping the tumor position in the tissue. Once identified, the resonant ultrasound frequency can be selected that will shatter the tumor.

 

Type: Utility: Non- Provisional
Application No: 18/122,124

 

Harmonic Excitation Tissue Therapy

 

Ref: OPENWP128-01

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 17, 2023
 
Short Summary

This invention uses ultrasonic signals to harmonically excite (shatter) abnormal tissue while propagating through healthy tissue without damaging the healthy tissue. In this way, the ultrasound signals can target the destruction of tumors (abnormal tissue). Selecting the correct resonant ultrasound frequency to destroy the tumor may include additional medical imaging (MRI) to assisting in identify the abnormal tissue and mapping the tumor position in the tissue. Once identified, the resonant ultrasound frequency can be selected that will shatter the tumor.

 

Type: Utility: PCT
Application No: PCT/US23/64662

 

Harmonic Excitation Tissue Therapy

Ref: OPENWP128-02

 

Country: United States
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 16, 2023
 
Short Summary

This invention uses ultrasonic signals to harmonically excite (shatter) abnormal tissue in conjunction with an anti-tumor agent to increase the susceptibility of a tumor. The anti-tumor agent is an immunotherapy or a large molecule anti-tumor biological agent (e.g. T cell therapy). Pairing the anti-tumor agent with the ultrasonic signals may increase neoantigen release from the tumor that primes an immune response from the patient. In this way, this therapy functions as an in situ vaccination against the tumor cells.

 

Type: Utility: Non- Provisional
Application No: 18/122,126

 

Harmonic Excitation Tissue Therapy

Ref: OPENWP128-02

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 16, 2023
 
Short Summary

This invention uses ultrasonic signals to harmonically excite (shatter) abnormal tissue in conjunction with an anti-tumor agent to increase the susceptibility of a tumor. The anti-tumor agent is an immunotherapy or a large molecule anti-tumor biological agent (e.g. T cell therapy). Pairing the anti-tumor agent with the ultrasonic signals may increase neoantigen release from the tumor that primes an immune response from the patient. In this way, this therapy functions as an in situ vaccination against the tumor cells.

 

Type: Utility: PCT
Application No: PCT/US23/64663

 

Harmonic Excitation Tissue Therapy

Ref: OPENWP128X

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date March 17, 2022
 
Short Summary

This invention uses ultrasonic signals to harmonically excite (shatter) abnormal tissue in conjunction with an anti-tumor agent to increase the susceptibility of a tumor. The anti-tumor agent is an immunotherapy or a large molecule anti-tumor biological agent (e.g. T cell therapy). Pairing the anti-tumor agent with the ultrasonic signals may increase neoantigen release from the tumor that primes an immune response from the patient. In this way, this therapy functions as an in situ vaccination against the tumor cells.

 

Type: Utility: Provisional
Application No: 63/321,056

 

Harmonic Excitation Tissue Therapy

Ref: OPENWP129

 

Country: United States
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 14, 2023
 
Short Summary

This invention is a therapy system that can be worn on the head to liquify blood clots that may cause (or be causing) a Large Vessel Occlusion. Ultrasound in a head wearable device directs a resonant ultrasound frequency to the blood clot to harmonically excite the blood clot and liquify the blood clot to become soluble to blood flowing through the head. A laser and a light sensor may be included in the wearable device to monitor the blood flow of the head and the ultrasound signal may be modulated in response to the optical imaging.

 

Type: Utility: Non- Provisional
Application No: 18/121,474

 

Clotlysis from Ultrasonic Harmonic Excitation

Ref: OPENWP129PC

 

Country: WIPO
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 17, 2023
 
Short Summary

This invention is a therapy system that can be worn on the head to liquify blood clots that may cause (or be causing) a Large Vessel Occlusion. Ultrasound in a head wearable device directs a resonant ultrasound frequency to the blood clot to harmonically excite the blood clot and liquify the blood clot to become soluble to blood flowing through the head. A laser and a light sensor may be included in the wearable device to monitor the blood flow of the head and the ultrasound signal may be modulated in response to the optical imaging.

 

Type: Utility: PCT
Application No: PCT/US23/64665

 

Clotlysis from Ultrasonic Harmonic Excitation

Ref: OPENWP129X

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date March 17, 2022
 
Short Summary

This invention is a therapy system that can be worn on the head to liquify blood clots that may cause (or be causing) a Large Vessel Occlusion. Ultrasound in a head wearable device directs a resonant ultrasound frequency to the blood clot to harmonically excite the blood clot and liquify the blood clot to become soluble to blood flowing through the head. A laser and a light sensor may be included in the wearable device to monitor the blood flow of the head and the ultrasound signal may be modulated in response to the optical imaging.

 

Type: Utility: Provisional
Application No: 63/321,060

 

Clotlysis from Ultrasonic Harmonic Excitation

Ref: OPENWP132

 

Country: United States
Status: Pending
Patent Number -
Issue Date -
Pub Number -
Filing Date March 27, 2023
 
Short Summary

This invention stabilizes the wavelength of pulsed lasers which is particularly important in speckle contrast measurements. A major cause of instability is temperature rise in the laser. In this invention, laser oscillator pre-pulses and laser amplifier pre-pulses are interleaved to stabilize the temperature of the laser. Specifically, the temperatures of the laser amplifier and laser oscillator rise in the pre- lasing stage to approximate the temperature of the lasing stage. In the pre-lasing stage, the laser oscillator and the laser amplifier are not driven at the same time so that no pulses are emitted during the pre-lasing stage. A further enhancement to this invention includes reducing the laser oscillator current and delaying the reduction of the laser oscillator current into the lasing stage. See FIG. 10.

 

Type: Utility: Non- Provisional
Application No: 18/126,855

 

Wavelength Stabilization of Pulsed Lasers

Ref: OPENWP132X

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number -
Filing Date March 28, 2022
 
Short Summary

This invention stabilizes the wavelength of pulsed lasers which is particularly important in speckle contrast measurements. A major cause of instability is temperature rise in the laser. In this invention, laser oscillator pre-pulses and laser amplifier pre-pulses are interleaved to stabilize the temperature of the laser. Specifically, the temperatures of the laser amplifier and laser oscillator rise in the pre- lasing stage to approximate the temperature of the lasing stage. In the pre-lasing stage, the laser oscillator and the laser amplifier are not driven at the same time so that no pulses are emitted during the pre-lasing stage. A further enhancement to this invention includes reducing the laser oscillator current and delaying the reduction of the laser oscillator current into the lasing stage. See FIG. 10.

 

Type: Utility: Provisional
Application No: 63/324,279

 

Wavelength Stabilization of Pulsed Lasers

Ref: WSGR apps

 

Country: United States
Status: Expired
Patent Number -
Issue Date -
Pub Number 2019/0072897
Filing Date March 7, 2019
 
Short Summary

This invention discloses methods and apparature to allow focusing and imaging of translucent materials with decreased size and complexity with improved focusing and imaging, so as to allow use in many fields. Many embodiments are discussed for use of this technology in a wide range of fields

 

Type: Utility: Non- Provisional
Application No: 16/056,805

 

Applications of Diffuse Medium Imaging